BlackRock Fund Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$30.7M Buy
2,034,263
+939,045
+86% +$13.3M 0.01% 1956
2016
Q3
$16.7M Buy
1,095,218
+52,118
+5% +$2.11M ﹤0.01% 2169
2016
Q2
$40.5M Buy
1,043,100
+72,160
+7% +$2.59M 0.01% 1631
2016
Q1
$27M Buy
970,940
+24,482
+3% +$816K 0.01% 1817
2015
Q4
$50.9M Buy
946,458
+59,661
+7% +$3.01M 0.01% 1454
2015
Q3
$35.5M Sell
886,797
-104,989
-11% -$3.42M 0.01% 1635
2015
Q2
$31.7M Buy
991,786
+14,840
+2% +$376K 0.01% 1820
2015
Q1
$23.3M Buy
976,946
+498,212
+104% +$11.2M 0.01% 1986
2014
Q4
$8.45M Buy
478,734
+73,388
+18% +$1.15M ﹤0.01% 2559
2014
Q3
$5.56M Sell
405,346
-16,647
-4% -$250K ﹤0.01% 2686
2014
Q2
$7.12M Buy
+421,993
New +$6.97M ﹤0.01% 2623

Other funds holding ITCI